Ziepert et al. (Ann. Oncol. 2008; 19(4):752) developed and validated a model that helps assess the risk of haematotoxicity in patients with aggressive NHL receiving CHOP-like regimens (www.toxcalculator.com). Risk can be calculated based on pre-treatment factors alone, or in combination with information on haematotoxicity during the first chemotherapy cycle.

Click here to access the haematotoxcalculator